Compare DraftKings Inc (DKNG) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance

DraftKings IncTrade

SELLAS Life Sciences Group Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

DraftKings Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? DraftKings Inc trades at $19.93 (market cap $9.86B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.27B). The key difference: DraftKings Inc is far larger — about 4.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, DraftKings Inc nearer its low. Which is the better fit depends on your goals.

	DKNG	SLS
Market Cap	$9.86B	$2.27B
Volume	16,584,596	4,179,659
Sector	Consumer Cyclical	Health
52-Week High	$36.24	$15.46
52-Week Low	$18.59	$1.39
Typical Hold Time	55 Days	—
Enterprise Value	$10.80B	$2.14B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DraftKings Inc

DraftKings (DKNG) trades at $19.15, down 3.04% on the day and near its 52-week low of $18.95, reflecting bearish technical momentum. Fundamentally, revenue grew to $6.05 billion in 2025 with a slight net profit of $3.71 million, but recent quarterly EPS misses and a negative net income margin of -2.68% for 2026 highlight profitability challenges. The stock's high P/E of 246.33 signals premium valuation despite operational improvements, including positive operating cash flow of $662.86 million in 2025.

The outlook is mixed: strong analyst consensus (75% buy ratings) and a $33.13 price target suggest upside potential from sportsbook growth and prediction market expansion, but risks include competitive pressures, regulatory uncertainty from Brazil's betting ban, and volatility from high valuation multiples. Investors face a trade-off between long-term growth prospects and near-term earnings instability.

SELLAS Life Sciences Group Inc. Common Stock

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKNG

DraftKings shares drop 19% in a month; Bank of America upgrades to Buy, signaling a possible bottom.24/7 Wall Street · 19 hours agoNeutral BofA upgrades DraftKings to 'Buy' citing growth in prediction markets and 45% upside potential.Proactive Investors · 3 days agoBullish Nasdaq hits record high driven by growth stocks despite cautious Dow and rising long-term yieldsFXEmpire · 3 days agoBullish View details →

SLS

View details →

About DraftKings Inc

DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.

About SELLAS Life Sciences Group Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.